000 01065 a2200289 4500
005 20250518090647.0
264 0 _c20201021
008 202010s 0 0 eng d
022 _a1365-2168
024 7 _a10.1002/bjs.11499
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBoland, M R
245 0 0 _aAuthor response to: Comment on: Meta-analysis of the impact of progesterone receptor status on oncological outcomes in oestrogen receptor-positive breast cancer.
_h[electronic resource]
260 _bThe British journal of surgery
_c03 2020
300 _a466-467 p.
_bdigital
500 _aPublication Type: Letter; Comment
650 0 4 _aBreast Neoplasms
_xdrug therapy
650 0 4 _aCarcinoma, Ductal, Breast
650 0 4 _aEstrogens
650 0 4 _aHumans
650 0 4 _aReceptors, Estrogen
650 0 4 _aReceptors, Progesterone
700 1 _aRyan, É J
700 1 _aLowery, A J
773 0 _tThe British journal of surgery
_gvol. 107
_gno. 4
_gp. 466-467
856 4 0 _uhttps://doi.org/10.1002/bjs.11499
_zAvailable from publisher's website
999 _c30703021
_d30703021